Sidson Pharma Distributors Private Limited - Due diligence report

A 360° intelligence report on Sidson Pharma Distributors Private Limited: trust score, financial health, credit view, compliance, directors,…

2014-01-03 Hyderabad, Telangana Active Unlisted Active Compliant
Share
SP Sidson Pharma Distributors Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Sidson Pharma Distributors Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
95/100
Trust Score
Low Risk

Sidson Pharma Distributors Private Limited is assessed as Low Risk with a Trust Score of 95/100. Sidson Pharma Distributors Private Limited is an active private limited indian non-government company incorporated in 2014, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Sidson Pharma Distributors Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
95/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
PHANI SRINIVAS RAMELLA 01234567 Director 01/04/2018 6 yrs Approved
PAIDIWAR SRINIVAS 01234567 Director 01/04/2018 6 yrs Approved
SATYA MURALI KRISHNA KAMMILA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2015)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Nova Sud Pharmaceuticals Private Limited
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 1 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Nova Sud Pharmaceuticals Private Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
EPFO headcount growing - hiring signal.
Operating for 12+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence95/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment79/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view89/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
05 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
29 Sep 2021
Director appointed
SATYA MURALI KRISHNA KAMMILA (Director)
30 Sep 2018
Director ceased
PAIDIWAR SRINIVAS
31 Mar 2018
Share transfer (FY 2018)
1.00000000 shares to PANINDIA PHARMA DISTRIBUTORS PRIVATE LIMITED
23 Oct 2017
Securities allotted
2000000 Equity Shares - 2.00 cr raised
16 Oct 2017
Director ceased
UDAYA LAKSHMI TADEPALLI
Director ceased
VENKATA SATYANARAYANA RAJU MANTENA
15 Oct 2017
Director appointed
PAIDIWAR SRINIVAS (Director)
30 Sep 2016
Director ceased
PHANI SRINIVAS RAMELLA
30 Aug 2016
Director appointed
PHANI SRINIVAS RAMELLA (Director)
03 Mar 2016
Securities allotted
2000000 Equity Shares - 2.00 cr raised
01 Mar 2015
Director ceased
SUCHITRA REDDY ANNAM
24 Sep 2014
Director ceased
SRINIVAS DUMDIGALLA
Director ceased
PRAVEEN KUMAR KODIPYAKA
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Shwetal Trading Private Limited U36999GJ2020PTC112994 Surat, Gujarat, India
Medihauxepharma U24233TG2014PTC094068 Hyderabad, Telangana, India
Minte U51101TG2016PTC102643 Hyderabad, Telangana, India
Janki Cokes Traders Private Limited U51909WB1998PTC085546 Kolkata, West Bengal, India
Crm Ispat Private Limited U27310WB2004PTC098223 Kolkata, West Bengal, India
Kshipan Estates And Enterprise Private Limited U17100GJ2015PTC082518 Ahmedabad, Gujarat, India
Bhuria International Private Limited U17299HR2019PTC081572 Rohtak, Haryana, India
Ravin Group U74210MH2009PTC196227 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Sidson Pharma Distributors Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Sidson Pharma Distributors Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Sidson Pharma Distributors Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 95/100, distress signals and MSME payment-delay disclosures - know whether Sidson Pharma Distributors Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Sidson Pharma Distributors Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Sidson Pharma Distributors Private Limited an active company?

Sidson Pharma Distributors Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Sidson Pharma Distributors Private Limited financially healthy?

Sidson Pharma Distributors Private Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Sidson Pharma Distributors Private Limited?

Its overall Trust Score is 95/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Sidson Pharma Distributors Private Limited?

The ultimate holding entity is Nova Sud Pharmaceuticals Private Limited. 3 active director(s) are on record.

Does Sidson Pharma Distributors Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Sidson Pharma Distributors Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Sidson Pharma Distributors Private Limited?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.